Senate Democrats Compare Prescription Drug Benefit Plans

Senate Democratic aides yesterday (July 15) released a side-by-side comparison of the leading Senate Democrat drug bill to the Senate tripartisan plan and the Republican package passed recently by the House. The chart was one of several documents released by Democrats.


ce

Senate sponsors of the tripartisan Medicare reform plan released a summary of their new bill yesterday (July 15). The legislation, which costs $370 billion over 10 years, would impose a $24 monthly premium. Click here for Summary Click here for Full Text Of Bill


/index.php?option=com_iwpfile&file=/dir_01/he2002_1902.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_1901.pdf

HP

FOR IMMEDIATE RELEASE:

July 15, 2002

Contact: Stacy Malkan,

202-234-0091; 202-321-6963 (cell)

FDA ISSUES PUBLIC HEALTH NOTIFICATION ON PHTHALATES IN MEDICAL DEVICES: ALTERNATIVES TO PVC SHOULD BE USED FOR PATIENTS RECEIVING CERTAIN MEDICAL TREATMENTS, AGENCY SAYS


/index.php?option=com_iwpfile&file=/dir_01/he2002_1899.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_1898.pdf

an

"We applaud Senators Charles Grassley (R-IA), Olympia Snowe (R-ME), John Breaux (D-LA) and Jim Jeffords (I-VT) for their focus on the issue of prescription drugs, but, after carefully reviewing legislative language, we believe it fails to meet the needs of seniors. In many important aspects, the proposal being prepared mirrors the poorly conceived legislation passed by the House last month. At least part of the proposal would rely on private, for-profit insurance carriers to define the prescription drug benefit available.


/index.php?option=com_iwpfile&file=/dir_01/he2002_1895.pdf

um

Statement by U.S. Senator Dianne Feinstein

- On the Split Vote by the President's Bioethics Council

on Nuclear Transplantation Stem Cell Research -

July 11, 2002

"The President's Council on Bioethics issued a report today that rightly condemns human reproductive cloning. Significantly, the President's hand-picked Council did not support efforts by the President and others - including a bill by Senator Sam Brownback (R-Kansas) - to ban critically important stem cell research that offers such hope to millions of Americans with incurable diseases.


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.